期刊文献+

血清microRNA的检测及临床应用进展 被引量:1

Progress of Serum microRNA Detection and Clinical Application
下载PDF
导出
摘要 microRNA(miRNA)能够通过与靶mRNA的3'非翻译区的互补序列特异性地结合而调节基因表达,在生命和病理过程中扮演着重要角色。近年来的研究结果显示,miRNA在血清中稳定表达,在疾病状态下其表达谱发生异常改变,因而可将血清miRNA作为潜在的生物标志物用于疾病的诊断,也可作为疾病治疗有效性的观察指标。目前,血清miRNA在肿瘤、免疫疾病、肝炎等的诊治中发挥着重要作用。现就血清miRNA的形成、检测方法及其在临床应用的进展予以综述。 MicroRNA(miRNA)regulates gene expression and plays a key role in many biological and pathological processes through binding to complementary sequences in the 3′UTR of target mRNA specifically.In recent years,studies have shown that miRNA has stable expression in serum,furthermore in some disease states their expression profiles have abnormal changes.Therefore,we can use serum miRNA as a potential biomarker for disease diagnosis and observed indicators of the effectiveness of the treatment.At present,serum miRNAs play a critical role in the diagnosis of tumors,immunological diseases and hepatitis.Here is to make a review on the progress of the serum miRNA formation,detection and clinical application.
出处 《医学综述》 2011年第23期3616-3618,共3页 Medical Recapitulate
关键词 MICRORNA 生物标志物 临床应用 MicroRNA Biomarker Clinical application
  • 相关文献

参考文献2

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献1056

同被引文献16

  • 1Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer[J]. Oral Oncol, 2009, 45(4-5): 309-316.
  • 2Nagadia R, Pandit P, Coman W B, et al. miRNAs in head and neck cancer revisited[J]. Cell Oncol (Dordr), 2013, 36(1): 1-7.
  • 3Warnakulasuriya S. Causes of oral cancer—an appraisal of controversies[J]. Br Dent J, 2009, 207(10): 471-475.
  • 4Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5): 843-854.
  • 5Malumbres M. miRNAs and cancer: an epigenetics view[J]. Mol Aspects Med, 2012, 34: 863-874.
  • 6Li J, Huang H, Sun L, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor[J]. Clin Cancer Res, 2009, 15(12): 3998-4008.
  • 7Yu Z W, Zhong L P, Ji T, et al. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines[J]. Oral Oncol, 2010, 46(4): 317-322.
  • 8Kozaki K, Imoto I, Mogi S, et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer[J]. Cancer Res, 2008, 68(7): 2094-2105.
  • 9Avissar M, Christensen B C, Kelsey K T, et al. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma[J]. Clin Cancer Res, 2009, 15(8): 2850-2855.
  • 10Liu C J, Kao S Y, Tu H F, et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer[J]. Oral Dis, 2010, 16(4): 360-364.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部